Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000929638-24-001069
Filing Date
2024-03-20
Accepted
2024-03-20 16:42:22
Documents
1
Period of Report
2024-03-18

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5274
  Complete submission text file 0000929638-24-001069.txt   6688
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Issuer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 7171 RUE FREDERICK BANTING SAINT-LAURENT A8 H4S 1Z9
Business Address
CHEUNG ANTHONY TZEYEW (Reporting) CIK: 0001998684 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41854 | Film No.: 24768318